ARTICLE | Company News

Ambrx, MabSpace in ADC deal

January 6, 2017 12:55 AM UTC

Ambrx Inc. (La Jolla, Calif.) and MabSpace Biosciences Co. Ltd. (Suzhou, China) said they plan to discover and develop antibody-drug conjugates for oncology. The partners will use MabSpace's humanized antibody technology in combination with Ambrx's EuCode conjugation platform.

The partners said they will share costs and rights to any resulting products in the global collaboration...